Cognivue Clarity characterizes mild cognitive impairment and Alzheimer’s disease in biomarker confirmed cohorts in the Bio-Hermes Study

Abstract The Bio-Hermes Study was a cross-sectional observational study designed to develop a database of blood-based and digital biomarkers to improve detection of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). We examined the ability of Cognivue Clarity to (a) detect MCI and AD in c...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	James E. Galvin, Michael J. Kleiman, Paul W. Estes, Heather M. Harris, Ernest Fung
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-10-01
Subjects:	Cognivue Bio-Hermes Alzheimer’s disease Mild cognitive impairment PET Amyloid
Online Access:	https://doi.org/10.1038/s41598-024-75304-5